Source: International Congress 2014 – Asthma: clinical problems
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Uematsu, J. Saito, Y. Suzuki, A. Fukuhara, S. Sato, K. Misa, Y. Nikaido, N. Fukuhara, X. Wang, Y. Tanino, T. Ishida, M. Munakata (Fukushima, Japan). Concomitant use of fractional exhaled nitric oxide (FeNO) and asthma control test (ACT) as markers for predicting asthma exacerbation. Eur Respir J 2014; 44: Suppl. 58, 4058

Member's Comments

No comment yet.

Related content which might interest you: Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) for predicting short-term treatment effect Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Meta-analysis of the accuracy of screening adult asthma using exhaled nitric oxide Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Combination of elevated exhaled nitric oxide and serum eosinophil cationic protein identifies asthma patients at risk for exacerbation Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Correlation of fractional exhaled nitric oxide (FeNO) and peripheral blood eosinophils (PBE) in refractory asthma Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 Relationships between exhaled nitric oxide and atopic profiles (mono-sensitization/poly-sensitization) in asthmatic patients Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Evaluation of fractional exhaled nitric oxide and peripheral blood eosinophil count as biomarkers in patients with refractory asthma Source: Annual Congress 2013 –Asthma Year: 2013 LATE-BREAKING ABSTRACT: Relationships between exhaled nitric oxide and lung function profiles in severe asthma Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Further evidence that FeNO directed therapy reduces asthma exacerbations Source: International Congress 2014 – Airway biomarkers Year: 2014 Exhaled nitric oxide (FeNO) levels to guide treatment for adults with asthma: A Cochrane systematic review Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Cost savings using fractional exhaled nitric oxide (FeNO) testing in asthma management by specialists Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 The association among inflammation-related genes, fractional exhaled nitric oxide (FeNO), and symptom severity in adult asthma: A structural equation model (SEM) Source: International Congress 2014 – Genes and environment in asthma and COPD Year: 2014 Validation of ATS cut-off points for FeNO in a clinical unselected population of subjects with possible asthma Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Characterization of airway inflammation in patients with asthma COPD overlap syndrome using FeNO levels Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Exhaled nitric oxide (FeNO) levels to guide treatment for children with asthma: A Cochrane systematic review Source: International Congress 2016 – Techniques and tools in paediatric asthma Year: 2016 Effect of environmental pollution on the control of bronchial asthma and fractional exhaled nitric oxide (FeNO) Source: Annual Congress 2013 –Outdoor and indoor environment: respiratory diseases from asthma to asbestosis Year: 2013 Validation of ATS guidelines for FeNO to monitor eosinophillic airway inflammation Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Associations between fractional exhaled nitric oxide (FeNO), asthma, respiratory symptoms and self-reported allergies in female university students in Kobe, Japan Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Interaction between airway calibre and exhaled NO: Impact on asthma control assessment Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 The role of FeNO measurement in exploration of respiratory symptoms in children with no diagnosis of asthma Source: International Congress 2015 – Paediatric epidemiology: pulmonary complications, bronchiolitis and asthma Year: 2015